Company’s specially appointed experts help drive enterprise development.

Jan 03,2020


For a company, development is the top priority, innovation is the primary driving force, and talent is the company’s most important resource for both development and innovation. To accelerate the company’s rapid growth and adapt to changing market demands, the company has specially appointed Researcher Mao Kairong as an expert.

  For a company, development is the primary priority, innovation is the driving force, and talent is the company’s most important resource for both development and innovation. To accelerate the company’s rapid growth and adapt to changing market demands, the company has specially appointed Researcher Mao Kairong as an expert.

 

 

  Mao Kairong, a researcher at the China National Veterinary Drug Administration, is China’s leading expert in the prevention and control of brucellosis and has extensive expertise in the development of products for the prevention and diagnosis of brucellosis. The company’s two products—the Brucella Red Plate Agglutination Test Antigen and the Brucella Tube Agglutination Test Antigen—were both developed under the technical guidance of Mao Kairong. Under the leadership of Researcher Mao Kairong, more products will be introduced to better serve the vast number of livestock farmers.


Hot News

Good news: Shengbo Bio and Sheng'ao Bio have both been approved for the Doctoral Innovation Station Construction Project!

Shengbo Bio and Sheng'ao Bio have both been recognized as recipients of the Doctoral Innovation Station Construction Project. This recognition is of great significance for enterprises in enhancing their innovation capabilities, optimizing their talent structure, and accelerating the commercialization of research findings.